Franklin Covey Company (FC) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Jul 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the FC SEC filings page.
Franklin Covey Company (FC) reported $262.7M in revenue over the twelve months to May 31, 2026, down 6.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025 shows a service business whose revenue softened, but fixed operating costs turned a modest sales decline into a sharp profit collapse.
The key shift is cost absorption: from FY2024 to FY2025, revenue fell7.0% while SG&A rose3.8% , squeezing operating results. Gross margin slipped only0.8 percentage points , whereas operating margin dropped9.4 percentage points , indicating that overhead—not the direct cost of delivery—drove most of the deterioration.
Cash conversion looks unusually high in FY2025 because operating cash flow of
The balance sheet became more financially constrained: the current ratio fell to 0.8x while liabilities reached
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Franklin Covey Company's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Franklin Covey Company has an operating margin of 2.1%, meaning the company retains $2 of operating profit per $100 of revenue. This results in a moderate score of 54/100, indicating healthy but not exceptional operating efficiency. This is down from 11.5% the prior year.
Franklin Covey Company's revenue declined 7.0% year-over-year, from $287.2M to $267.1M. This contraction results in a growth score of 23/100.
Franklin Covey Company's current ratio of 0.82 is below the typical benchmark, resulting in a score of 12/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Franklin Covey Company converts 7.8% of revenue into free cash flow ($20.7M). This strong cash generation earns a score of 71/100.
Franklin Covey Company earns a strong 4.6% return on equity (ROE), meaning it generates $5 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 78/100. This is down from 28.1% the prior year.
Franklin Covey Company scores 2.49, placing it in the grey zone between 1.81 and 2.99. The largest contribution to the score comes from revenue of $267.1M against total assets of $242.9M. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Franklin Covey Company passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.
For every $1 of reported earnings, Franklin Covey Company generates $9.44 in operating cash flow ($29.0M OCF vs $3.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Franklin Covey Company earns $10.10 in operating income for every $1 of interest expense ($5.7M vs $565K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Franklin Covey Company generated $67.8M in revenue in Q3 2026. This represents an increase of 1.0% from the same quarter a year earlier. Against the prior quarter it is up 13.7%.
Franklin Covey Company's EBITDA was $5.4M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Franklin Covey Company reported $3.1M in net income in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Franklin Covey Company earned $0.27 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cash & Balance Sheet
Franklin Covey Company recorded an outflow of $32K in free cash flow in Q3 2026, representing a cash shortfall after capex. This represents a decrease of 100.7% from the same quarter a year earlier. Against the prior quarter it is down 100.2%.
Franklin Covey Company held $12.0M in cash as of Q3 2026; no long-term debt figure is on record for that period.
Not reported for Q3 2026.
Margins & Returns
Franklin Covey Company's gross margin was 73.9% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 2.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.0 percentage points.
Franklin Covey Company's operating margin was 6.2% in Q3 2026, reflecting core business profitability. This is up 9.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 9.5 percentage points.
Franklin Covey Company's net profit margin was 4.5% in Q3 2026, showing the share of revenue converted to profit. This is up 6.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 7.9 percentage points.
Franklin Covey Company's quarterly ROE was 7.2% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 9.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 12.4 percentage points.
Capital Allocation
Franklin Covey Company spent $7K on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 99.9% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.
Franklin Covey Company invested $1.2M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 35.0% from the same quarter a year earlier. Against the prior quarter it is up 11.7%.
Not reported for Q3 2026.
FC Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $67.8M+1.0% | $59.6M+0.1% | $64.0M-7.3% | $71.2M-15.3% | $67.1M-8.5% | $59.6M-2.8% | $69.1M+1.0% | $84.1M+7.9% |
| Cost of Revenue | $17.7M+12.1% | $14.4M+3.7% | $15.7M-4.3% | $17.5M-5.1% | $15.8M-8.0% | $13.9M-4.3% | $16.4M+1.6% | $18.4M-1.4% |
| Gross Profit | $50.1M-2.4% | $45.3M-1.0% | $48.4M-8.2% | $53.8M-18.2% | $51.3M-8.7% | $45.7M-2.4% | $52.7M+0.8% | $65.7M+10.8% |
| SG&A Expenses | $43.3M-6.4% | $43.5M-3.5% | $46.1M-2.3% | $44.2M-3.7% | $46.2M+2.5% | $45.1M+10.6% | $47.2M+6.8% | $45.9M-0.2% |
| Operating Income | $4.2Mn/m | -$2.0Mn/m | -$3.7M-347.5% | $7.9M-56.0% | -$2.2M-126.4% | -$1.5M-200.9% | $1.5M-72.3% | $17.9M+69.6% |
| EBITDA | $5.4Mn/m | -$859Kn/m | -$2.6M-205.2% | $13.4M-41.9% | -$1.2M-112.8% | -$439K-118.6% | $2.4M-62.2% | $23.0M+43.9% |
| Interest Expense | $54K-60.0% | $92K-41.0% | $95K-46.6% | $96K-52.7% | $135K-45.3% | $156K-52.4% | $178K-47.8% | $203K-50.5% |
| Income Tax | $1.1Mn/m | -$80Kn/m | -$343K-184.5% | $3.6M-40.6% | -$718K-127.2% | -$272K-150.3% | $406K-4.5% | $6.0M+66.1% |
| Net Income | $3.1Mn/m | -$2.0Mn/m | -$3.3M-378.5% | $4.4M-63.4% | -$1.4M-124.6% | -$1.1M-223.1% | $1.2M-75.7% | $12.0M+75.5% |
| EPS (Basic) | $0.27n/m | -$0.17n/m | -$0.27-400.0% | $0.34-62.6% | -$0.11-125.6% | -$0.08-214.3% | $0.09-75.7% | $0.91+78.4% |
| EPS (Diluted) | $0.27n/m | -$0.17n/m | -$0.27-400.0% | $0.34-61.8% | -$0.11-125.6% | -$0.08-233.3% | $0.09-75.0% | $0.89+85.4% |
| Diluted Shares (Avg) | 11M-11.2% | 11M-12.8% | 12M-8.0% | N/A | 13M-3.6% | 13M-2.8% | 13M-2.7% | N/A |
Not reported in any period shown, so not listed: R&D Expenses.
FC Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $198.0M-9.3% | $206.5M-6.7% | $221.3M-7.8% | $242.9M-7.1% | $218.3M-1.2% | $221.3M-0.3% | $239.9M+9.6% | $261.5M+6.4% |
| Current Assets | $91.8M-17.3% | $95.4M-21.2% | $109.0M-21.4% | $129.5M-19.2% | $111.0M-7.5% | $121.0M-1.1% | $138.8M+18.4% | $160.3M+10.5% |
| Cash & Equivalents | $12.0M-64.5% | $13.7M-66.0% | $17.5M-67.1% | $31.7M-34.9% | $33.7M-7.8% | $40.4M-1.2% | $53.3M+56.9% | $48.7M+27.3% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Inventory | $5.8M+42.9% | $5.3M+30.3% | $5.3M+38.5% | $5.2M+29.1% | $4.1M-12.5% | $4.1M-2.4% | $3.8M-7.0% | $4.0M-5.0% |
| Accounts Receivable | $50.3M+0.9% | $50.2M-5.8% | $59.1M-3.7% | $68.4M-20.4% | $49.8M-17.5% | $53.3M-6.8% | $61.4M+2.6% | $86.0M+5.0% |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | $31.2M0.0% | $31.2M0.0% | $31.2M0.0% | $31.2M0.0% | $31.2M0.0% | $31.2M0.0% | $31.2M0.0% | $31.2M0.0% |
| Total Liabilities | $155.1M+1.6% | $168.4M+13.2% | $167.3M+5.0% | $176.0M-1.3% | $152.7M+2.6% | $148.8M-1.5% | $159.3M+7.4% | $178.4M+6.7% |
| Current Liabilities | $140.1M+5.9% | $152.2M+13.5% | $148.7M+3.6% | $157.3M-3.2% | $132.3M-3.1% | $134.1M-3.2% | $143.5M+6.6% | $162.5M+7.1% |
| Non-Current Liabilities | $14.9M-26.7% | $16.2M+9.9% | $18.5M+17.8% | $18.7M+17.3% | $20.4M+67.0% | $14.7M+16.6% | $15.7M+15.3% | $16.0M+2.1% |
| Total Equity | $42.9M-34.5% | $38.0M-47.5% | $54.0M-33.0% | $66.9M-19.5% | $65.6M-9.1% | $72.5M+2.4% | $80.6M+14.4% | $83.1M+5.7% |
| Retained Earnings | $124.1M+1.8% | $121.0M-1.9% | $123.0M-1.1% | $126.3M+2.5% | $121.9M+9.6% | $123.3M+16.9% | $124.4M+18.9% | $123.2M+23.4% |
Not reported in any period shown, so not listed: Long-Term Debt.
FC Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1M-82.0% | $16.3Mn/m | $98K-99.3% | $9.9M-54.6% | $6.3M-23.4% | -$1.4M-110.7% | $14.1M-18.9% | $21.9M+123.4% |
| Depreciation & Amortization | $1.2M+17.1% | $1.1M+12.2% | $1.1M+15.7% | $1.1M+19.3% | $1.0M+2.2% | $1.0M+11.3% | $950K-12.9% | $911K-20.1% |
| Stock-Based Compensation | $1.5M-32.5% | $2.7M+97.9% | $1.4M-34.1% | N/A | $2.2M-21.6% | $1.3M-1.6% | $2.2M-25.2% | N/A |
| Capital Expenditures | $1.2M-35.0% | $1.0M-18.6% | $1.7M+73.0% | $4.2M+290.6% | $1.8M+97.2% | $1.3M+97.7% | $998K-6.9% | $1.1M+10.9% |
| Free Cash Flow | -$32K-100.7% | $15.2Mn/m | -$1.6M-112.4% | $5.7M-72.4% | $4.5M-38.3% | -$2.6M-121.8% | $13.1M-19.7% | $20.8M+135.8% |
| Investing Cash Flow | -$2.2Mn/m | -$3.1Mn/m | -$3.8Mn/m | -$8.4Mn/m | -$3.5Mn/m | -$2.2Mn/m | -$2.8Mn/m | -$3.5Mn/m |
| Financing Cash Flow | -$524Kn/m | -$17.2Mn/m | -$10.4Mn/m | -$3.2Mn/m | -$9.7Mn/m | -$9.3Mn/m | -$6.6Mn/m | -$6.7Mn/m |
| Share Buybacks | $7K-99.9% | $17.4M+100.3% | $10.7M+79.3% | $3.4M-31.0% | $8.3M+12.1% | $8.7M+313.5% | $6.0M-63.5% | $4.9M-16.6% |
Not reported in any period shown, so not listed: Dividends Paid.
FC Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.9%-2.6pp | 75.9%-0.8pp | 75.5%-0.8pp | 75.5%-2.6pp | 76.5%-0.1pp | 76.7%+0.4pp | 76.3%-0.1pp | 78.1%+2.1pp |
| Operating Margin | 6.2%+9.5pp | -3.4%-0.9pp | -5.7%-7.8pp | 11.1%-10.2pp | -3.3%-14.6pp | -2.4%-4.8pp | 2.1%-5.6pp | 21.3%+7.8pp |
| Net Margin | 4.5%+6.7pp | -3.3%-1.5pp | -5.1%-6.9pp | 6.1%-8.1pp | -2.1%-9.9pp | -1.8%-3.2pp | 1.7%-5.4pp | 14.2%+5.5pp |
| Return on Equity | 7.2%+9.3pp | -5.2%-3.7pp | -6.1%-7.5pp | 6.5%-7.9pp | -2.1%-10.1pp | -1.5%-2.7pp | 1.5%-5.4pp | 14.4%+5.7pp |
| Return on Assets | 1.6%+2.2pp | -1.0%-0.5pp | -1.5%-2.0pp | 1.8%-2.8pp | -0.7%-3.2pp | -0.5%-0.9pp | 0.5%-1.7pp | 4.6%+1.8pp |
| Current Ratio | 0.66-0.2x | 0.63-0.3x | 0.73-0.2x | 0.82-0.2x | 0.840.0x | 0.900.0x | 0.97+0.1x | 0.990.0x |
| Liabilities-to-Equity | 3.61+1.3x | 4.43+2.4x | 3.10+1.1x | 2.63+0.5x | 2.33+0.3x | 2.05-0.1x | 1.97-0.1x | 2.150.0x |
| Asset Turnover | 0.340.0x | 0.290.0x | 0.290.0x | 0.290.0x | 0.310.0x | 0.270.0x | 0.290.0x | 0.320.0x |
| FCF Margin | -0.1%-6.7pp | 25.5%+29.9pp | -2.5%-21.6pp | 8.1%-16.7pp | 6.7%-3.2pp | -4.4%-24.2pp | 19.0%-4.9pp | 24.7%+13.4pp |
Not reported in any period shown, so not listed: Debt-to-Equity.
Note: The current ratio is below 1.0 (0.82), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Franklin Covey Company FC | FY2025 | $267.1M | $3.1M | 1.1% | $211.0M | 44/100 |
| 51Talk Online Education Group COE | FY2025 | $95.6M | -$16.8M | -17.6% | $70.5M | 60/100 |
| CHEGG, INC. CHGG | FY2025 | $376.9M | -$103.4M | -27.4% | $78.0M | 21/100 |
| Legacy Education Inc. LGCY | FY2026 | $80.1M | $9.1M | 11.4% | $131.3M | 81/100 |
| iHuman Inc. IH | FY2025 | $115.4M | $13.6M | 11.8% | $58.3M | 54/100 |
| Sunlands Technology Group STG | FY2025 | $288.8M | $52.3M | 18.1% | $31.1M | 61/100 |
Where Franklin Covey Company Ranks
Frequently Asked Questions
What is Franklin Covey Company's annual revenue?
Franklin Covey Company (FC) reported $267.1M in total revenue for fiscal year 2025. This represents a -7.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Franklin Covey Company's revenue growing?
Franklin Covey Company (FC) revenue declined by 7.0% year-over-year, from $287.2M to $267.1M in fiscal year 2025.
Is Franklin Covey Company profitable?
Yes, Franklin Covey Company (FC) reported a net income of $2.2M over the trailing 12 months to May 31, 2026. In fiscal year 2025 it reported a net income of $3.1M, with a net profit margin of 1.1%.
What is Franklin Covey Company's EBITDA?
Franklin Covey Company (FC) had EBITDA of $14.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Franklin Covey Company's gross margin?
Franklin Covey Company (FC) had a gross margin of 76.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Franklin Covey Company's operating margin?
Franklin Covey Company (FC) had an operating margin of 2.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Franklin Covey Company's net profit margin?
Franklin Covey Company (FC) had a net profit margin of 1.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Franklin Covey Company's return on equity (ROE)?
Franklin Covey Company (FC) has a return on equity of 4.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Franklin Covey Company's free cash flow?
Franklin Covey Company (FC) generated $20.7M in free cash flow during fiscal year 2025. This represents a -63.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Franklin Covey Company's operating cash flow?
Franklin Covey Company (FC) generated $29.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Franklin Covey Company's total assets?
Franklin Covey Company (FC) had $242.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Franklin Covey Company's capital expenditures?
Franklin Covey Company (FC) invested $8.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Franklin Covey Company's current ratio?
Franklin Covey Company (FC) had a current ratio of 0.82 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Franklin Covey Company's liabilities-to-equity ratio?
Franklin Covey Company (FC) had a liabilities-to-equity ratio of 2.63 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.
What is Franklin Covey Company's return on assets (ROA)?
Franklin Covey Company (FC) had a return on assets of 1.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Franklin Covey Company's P/E ratio?
Franklin Covey Company (FC) trades at 96.5x earnings, its market capitalization divided by $2.2M net income, trailing 12 months to May 31, 2026. The market capitalization is $211.0M as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Franklin Covey Company's price-to-sales ratio?
Franklin Covey Company (FC) trades at 0.8x sales, its market capitalization divided by $262.7M revenue, trailing 12 months to May 31, 2026. The market capitalization is $211.0M as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Franklin Covey Company's Altman Z-Score?
Franklin Covey Company (FC) has an Altman Z-Score of 2.49, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Franklin Covey Company's Piotroski F-Score?
Franklin Covey Company (FC) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Franklin Covey Company's earnings high quality?
Franklin Covey Company (FC) has an earnings quality ratio of 9.44x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Franklin Covey Company cover its interest payments?
Franklin Covey Company (FC) has an interest coverage ratio of 10.10x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Franklin Covey Company?
Franklin Covey Company (FC) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.